These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35948625)

  • 1. Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model.
    Dai L; Mugaanyi J; Cai X; Dong M; Lu C; Lu C
    Sci Rep; 2022 Aug; 12(1):13639. PubMed ID: 35948625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma.
    Xu L; Yang H; Yan M; Li W
    Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
    Qiu MJ; Zhang L; Chen YB; Zhu LS; Zhang B; Li QT; Yang SL; Xiong ZF
    Int J Biochem Cell Biol; 2021 Aug; 137():106037. PubMed ID: 34217812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 6. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
    Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z
    Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Chen J; Yang J; Xu Q; Wang Z; Wu J; Pan L; Huang K; Wang C
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33605411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase‑1 expression is regulated by HIF‑1‑dependent and epigenetic mechanisms and serves a tumor‑suppressive role in gastric cancer progression.
    Ito K; Kitajima Y; Kai K; Matsufuji S; Yamada K; Egawa N; Kitagawa H; Okuyama K; Tanaka T; Noshiro H
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.
    Xu JH; Guan YJ; Qiu ZD; Zhang X; Zi LL; Zhou Y; Chen C; Yu J; Zhang YC; Wang WX
    Oxid Med Cell Longev; 2021; 2021():6485871. PubMed ID: 34795841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma.
    Chen D; Feng Z; Zhou M; Ren Z; Zhang F; Li Y
    Biomed Res Int; 2021; 2021():4092635. PubMed ID: 34746301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
    Lin T; Lin Z; Mai P; Zhang E; Peng L
    Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of
    Zhao S; Yu M
    DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of an immune-related LncRNA prognostic model for hepatocellular carcinoma.
    Xin C; Huang B; Chen M; Yan H; Zhu K; Chen L; Jiang C; Zhang J; Wu Y
    Cytokine; 2022 Aug; 156():155923. PubMed ID: 35667281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma.
    Zhang G; Li T; Tan G; Song Y; Liu Q; Wang K; Ai J; Zhou Z; Li W
    Cancer Med; 2022 Jun; 11(12):2516-2530. PubMed ID: 35426219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
    Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
    Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
    Wang N; Zhou X; Tang F; Wang X; Zhu X
    Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells.
    Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B
    BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.